Azitra (AZTR) Total Liabilities (2022 - 2026)
Azitra's (AZTR) quarterly Total Liabilities came in at $1.6 million in Q1 2026, up 9.75% YoY from $1.5 million in Q1 2025, and up 34.5% on a QoQ basis from $1.2 million in Q4 2025.
Azitra (AZTR) Total Liabilities (2022 - 2026) Analysis & Trends
Azitra (AZTR) has 5 years of Total Liabilities data on file, last reported at $1.6 million in Q1 2026.
- Quarterly Total Liabilities rose 9.75% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (up 9.75% YoY) and the FY2025 annual result came in at $1.2 million, down 26.28% from the prior year.
- Total Liabilities rose to $1.6 million in Q1 2026, from $1.2 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $9.7 million in Q4 2022 to a low of $1.2 million in Q4 2025.
- A 5-year average of $2.5 million and a median of $1.7 million in 2024 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2023 — Total Liabilities sank 77.37% — and 2025, when it advanced 17.56%.
- Tracing AZTR's Total Liabilities over 5 years: stood at $9.7 million in 2022, then sank by 77.37% to $2.2 million in 2023, then decreased by 24.6% to $1.7 million in 2024, then slipped by 26.28% to $1.2 million in 2025, then soared by 34.5% to $1.6 million in 2026.
- The last three Total Liabilities figures came in at $1.6 million (Q1 2026), $1.2 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.70 Bn | 131.85 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.75 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 65.36 Bn | 60.18 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 59.15 Bn | 54.01 Bn | 52.00 Mn | 4.20 Bn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn | 4.00 Bn |
| 6 | Alnylam Pharmaceuticals | 31.88 Bn | 28.57 Bn | 992.69 Mn | 4.20 Bn |
| 7 | BioNTech SE | 28.14 Bn | 9.75 Bn | 668.28 Mn | 3.22 Bn |
| 8 | Insmed | 27.59 Bn | 26.43 Bn | 358.27 Mn | 1.35 Bn |
| 9 | Royalty Pharma | 27.31 Bn | 26.48 Bn | - | 10.03 Bn |
| 10 | Azitra | 2.61 Mn | 2.61 Mn | - | 1.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.58 Mn |
| Mar 31, 2026 | 1.65 Mn |
| Dec 31, 2025 | 1.22 Mn |
| Sep 30, 2025 | 2.02 Mn |
| Jun 30, 2025 | 1.73 Mn |
| Mar 31, 2025 | 1.50 Mn |
| Dec 31, 2024 | 1.66 Mn |
| Sep 30, 2024 | 1.72 Mn |
| Jun 30, 2024 | 2.16 Mn |
| Mar 31, 2024 | 1.74 Mn |
| Dec 31, 2023 | 2.20 Mn |
| Sep 30, 2023 | 2.16 Mn |
| Jun 30, 2023 | 2.59 Mn |
| Dec 31, 2022 | 9.73 Mn |